Prostamax Injectable
Prostamax 20 mg contains the KEDP tetrapeptide (Lys-Glu-Asp-Pro), a synthetic bioregulator developed by Russian researcher Vladimir Khavinson for prostate tissue research. It belongs to the Khavinson short peptide class, which is investigated for proposed epigenetic mechanisms involving direct interaction with DNA and modulation of gene expression in target tissues.
In research contexts, Prostamax is studied for its potential effects on prostate cellular function, including chromatin remodeling and gene expression regulation. The single PubMed-indexed canonical study reports that Prostamax incubation reactivates constitutive heterochromatin and rRNA-gene transcription in peripheral-blood lymphocytes from older donors. Preclinical animal models have investigated its effects on prostate tissue morphology and inflammatory markers.
In bodybuilding and men's health contexts, Prostamax is referenced anecdotally for supporting prostate function and urinary comfort, particularly during or after anabolic steroid cycles. However, all published research originates from a single Russian research program, no independent Western replication exists, and no human clinical trials have been conducted. Such use falls outside any approved indication, and Prostamax has no FDA-approved human product.
Research Properties of Prostamax 20 mg
- KEDP tetrapeptide sequence (Lys-Glu-Asp-Pro)
- Proposed epigenetic modulation of prostate gene expression
- Investigated for chromatin remodeling and heterochromatin decondensation
- Lyophilized powder format for extended stability
- 20 mg per vial for research applications
KEDP Tetrapeptide Bioregulator
Prostamax belongs to the Khavinson bioregulator class, a family of ultrashort peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology for proposed tissue-specific regulatory effects. The KEDP sequence (Lys-Glu-Asp-Pro) is specifically associated with prostate tissue in this research framework.
The proposed mechanism involves direct interaction with DNA and core histones after cellular penetration. Khavinson peptides are thought to bind to specific promoter regions, modulating chromatin accessibility and enabling transcription of genes associated with tissue homeostasis. The single PubMed-indexed Prostamax study reports heterochromatin decondensation and increased rRNA-gene transcription in lymphocyte cultures from older donors.
Critically, the canonical study used peripheral blood lymphocytes, not prostate tissue, so direct prostate-selective activity has not been demonstrated in that report. No pharmacokinetic studies have been published, and the proposed direct peptide-DNA binding mechanism remains outside mainstream molecular biology.
Defining Characteristic
Proposed Epigenetic Mechanism
Prostamax is proposed to act through direct DNA interaction and gene expression modulation rather than cell-surface receptor binding. This epigenetic mechanism differs fundamentally from conventional prostate medications (alpha-blockers, 5-alpha reductase inhibitors).
Prostamax 20 mg vs Other Dragon Pharma Preparations
Dragon Pharma offers several Khavinson bioregulators and research peptides with different tissue targets. Testagen is the KEDG tetrapeptide investigated for endocrine regulation. Vesugen is the KED tripeptide for vascular endothelium. Prostamax's KEDP sequence shares the N-terminal three residues with Vesugen but adds proline at the C-terminus, which is proposed to confer prostate tissue specificity.
Typical Dosage Ranges
Common reference ranges for Prostamax are derived primarily from Russian bioregulator protocols and community practices rather than controlled clinical trials. The standard pattern involves short cycles of 10–20 days with daily administration, followed by extended rest periods. No dose-response studies have been conducted, and the relationship between dose and any proposed effect is unknown.
| Use Case |
Common Reference Range |
Frequency |
| Standard research cycle |
10–20 mg |
Daily for 10–20 days |
| Community protocol (injectable) |
2 mg (20 clicks) |
Daily for 10 days |
| Maintenance/longevity |
10 mg |
10–15 days per cycle |
Reconstitution & Handling
Prostamax 20 mg is supplied as a lyophilized powder requiring reconstitution. Bacteriostatic Water is commonly referenced for reconstituting research peptides. A 20 mg vial reconstituted with 2 mL yields a concentration of 10 mg/mL. Slowly inject the diluent against the vial wall and gently swirl until fully dissolved. Store reconstituted solution at 2–8°C and use within 30 days.
Stacking & Research Considerations
In Khavinson bioregulator protocols, Prostamax is sometimes referenced alongside other tissue-specific peptides. Testagen (testicular/HPG axis) is the most commonly mentioned companion in urogenital research contexts. However, no controlled studies have examined the safety or efficacy of these combinations.
Important
Individual Response Varies
The information above is for educational reference and does not constitute medical advice. Prostamax has not been evaluated by the FDA for safety or efficacy.
Important Safety Information
No formal safety data exists for Prostamax. All published research originates from a single Russian research program, and no independent Western replication or controlled human trials have been conducted. Pharmacokinetics, bioavailability, and optimal dosing in humans are completely uncharacterized.
Important
Non-Medical Use
Non-medical use of Prostamax falls outside any approved indication. Product purity does not establish that non-medical use is safe or appropriate for an individual. Material sold online is research-chemical grade, not pharmaceutical grade.
Potential Adverse Effects
Reported side effects in limited sources include injection site pain and rare local redness. Because Prostamax is proposed to interact with DNA and modulate gene expression, theoretical risks include unintended effects on cellular regulation, particularly at heterochromatin or rRNA-gene level. No long-term safety or carcinogenicity data exist.
Conditions Requiring Medical Evaluation
Individuals with active prostate cancer or strong family history, known hypersensitivity to peptide products, or pregnancy/breastfeeding status should exercise particular caution. No formal contraindication list exists for Prostamax because it has not undergone Western regulatory review.
Monitoring Considerations
If Prostamax is used in any research context, monitoring of prostate-specific markers may be considered, though no standardized protocol exists. Laboratory testing of the product itself is separate from clinical monitoring of the individual.
Product Care
Storage & Handling
Store lyophilized powder at -20°C for long-term storage (up to 2 years) or 2–8°C for up to 6 months, protected from light and moisture. Reconstituted solution should be stored at 2–8°C and used within 4 weeks. Do not freeze after reconstitution.
Keep all research peptides and injectable products out of the reach of children.
Further Safety Information
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with no external product details. Products are supplied through the official Dragon Pharma distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is available
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Prostamax 20 mg product, use the security code on the vial label and cross-check it on the official Dragon Pharma site. Verify that the labelled sequence is Lys-Glu-Asp-Pro (KEDP) before purchase. Original packaging and batch documentation help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Recommended Conditions
Store lyophilized powder at -20°C for long-term storage (up to 2 years) or 2–8°C for up to 6 months, protected from light and moisture. The unopened vial should be kept under conditions that preserve the peptide's structural integrity until reconstitution.
Once reconstituted, Prostamax solution should be stored at 2–8°C and used within 4 weeks. Do not freeze reconstituted solution. Discard if solution becomes cloudy or develops particulate matter.
Keep out of reach of children. Follow proper handling practices for research peptides and use appropriate sterile technique during reconstitution.
Quick Reference
Do & Don't
- Do store lyophilized powder at -20°C for long-term storage
- Do protect from light and moisture
- Do use reconstituted solution within 4 weeks
- Don't freeze reconstituted solution
- Don't expose to excessive heat
- Don't use if powder appears discolored
What is Prostamax 20 mg used for?
Prostamax 20 mg is a research peptide supplied as a lyophilized powder. It contains the KEDP tetrapeptide, which is investigated for proposed epigenetic effects on prostate tissue gene expression. There is no FDA-approved human indication for Prostamax.
How often should Prostamax 20 mg be administered?
Common reference ranges for Prostamax are derived from Russian bioregulator protocols. Standard patterns involve 10–20 mg daily for 10–20 days, followed by extended rest periods. No dose-response studies have been conducted.
Does Prostamax 20 mg require PCT?
Prostamax is not an anabolic steroid and does not suppress endogenous testosterone production. Post-cycle therapy designed for steroid cycles is not applicable. Its proposed epigenetic mechanism is distinct from hormonal suppression.
What does Prostamax do?
Prostamax is proposed to penetrate cell nuclei and interact with DNA to modulate gene expression in prostate tissues. The single PubMed-indexed study reports heterochromatin decondensation in lymphocytes, not prostate cells. These mechanisms remain investigational and have not been independently validated.
How long does Prostamax take to work?
No established onset timeline exists for Prostamax in humans because no controlled trials have been completed. Its proposed epigenetic mechanism would theoretically involve gene expression changes that develop over days to weeks.
Is Prostamax the best prostate peptide?
No single prostate peptide is universally superior. Prostamax has the thinnest evidence base of the Khavinson peptides, with most data appearing in comparative studies rather than dedicated investigations.
What is the difference between Prostamax and Testagen?
Prostamax (KEDP) and Testagen (KEDG) are both Khavinson tetrapeptides but have different amino acid sequences and proposed tissue targets. Prostamax is associated with prostate tissue, while Testagen targets the testicular/HPG axis.
What is the difference between Prostamax and Vesugen?
Prostamax (KEDP) and Vesugen (KED) share the N-terminal three residues but differ at the C-terminus. Prostamax adds proline, which is proposed to confer prostate tissue specificity, while Vesugen targets vascular endothelium.
Is 20 mg of Prostamax a lot?
20 mg is the total labeled content of the Prostamax 20 mg vial. Because no standardized human dosage exists for this research peptide, the milligram amount cannot be classified as high or low relative to established protocols.
What strength is Prostamax 20 mg?
Prostamax 20 mg by Dragon Pharma contains 20 mg of Prostamax per vial as a lyophilized powder. The vial size is 2 mL. This is a research presentation.
Can Prostamax be stacked with other peptides?
In Khavinson bioregulator protocols, Prostamax is sometimes referenced alongside other tissue-specific peptides. Testagen is the most commonly mentioned companion in urogenital research contexts. However, no controlled studies have examined these combinations.
No reviews found
Please log in to write Prostamax 20 mg review.
